Coagulopathy (main): Difference between revisions
| Line 7: | Line 7: | ||
*[[Bleeding Treatments]] | *[[Bleeding Treatments]] | ||
*[[Procedures in patients with coagulopathies]] | *[[Procedures in patients with coagulopathies]] | ||
* | *[[Anticoagulant reversal]] (known medications) | ||
**[[Warfarin (Coumadin) Reversal]] | **[[Warfarin (Coumadin) Reversal]] | ||
**[[Dabigatran (Pradaxa) Reversal]] | **[[Dabigatran (Pradaxa) Reversal]] | ||
Revision as of 07:44, 25 March 2016
Differential Diagnosis
Coagulopathy
Platelet Related
- Too few
- Nonfunctional
Factor Related
- Acquired (Drug Related)
- Warfarin (Coumadin)
- Unfractionated heparin
- Low molecular weight heparin (i.e. enoxaparin (Lovenox), dalteparin)
- Factor Xa Inhibitors (e.g. rivaroxaban, apixaban, fondaparinux, edoxaban)
- Direct thrombin inhibitors (e.g. dabigatran, argatroban, bivalirudin)
- Illness induced
- Genetic
Increased Clotting
Managment
- Bleeding Treatments
- Procedures in patients with coagulopathies
- Anticoagulant reversal (known medications)